Trial intelligence / Profile preview

Tenofovir in Pregnancy (TiP) Study

NCT01125696Phase 2Completed

Sponsor
Centers for Disease Control and Prevention
Start
May 2012
Primary completion
May 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of tenofovir in human immunodeficiency virus infection (HIV), hepatitis B (HBV), sponsored by Centers for Disease Control and Prevention. Started May 2012; status: completed.

02

Drugs

tenofovir
03

Conditions

human immunodeficiency virus infection (HIV)hepatitis B (HBV)

Beyond the preview

Go deeper on NCT01125696.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01125696.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call